Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Clin Cancer Res. 2023 Dec 1;29(23):4863–4869. doi: 10.1158/1078-0432.CCR-23-0585

Table 2.

Whole study cohort as well as subgroup volumetric and growth rate results.

Group Volumes (cc) Absolute Growth Rate (AGR; cc/yr)
Baseline Last on Tx Best Response Before treatment First year Entire duration
Whole Group (n=12) Mean 29.5 25.3 23.8 8.0 −0.2 −1.2
±SD 32.1 22.0 22.5 7.7 7.9 10.6
p-value ns 0.09 0.05 0.05
Grade 2 (N=8) Mean 36.4 28.5 27.6 7.9 −1.9 −5.6
±SD 37.2 24.8 25.6 8.4 8.3 7.4
p-value ns 0.07 0.09 0.04
Grade 3 (N=4) Mean 15.8 18.8 16.2 8.0 3.2 7.5
±SD 13.3 16.1 14.2 7.3 6.9 11.5
p-value ns ns ns ns
Small Tumors (n=6) Mean 7.4 10.2 8.0 2.1 3.2 2.1
±SD 5.1 6.5 5.1 1.6 4.9 5.0
p-value ns ns ns ns
Large Tumors (n=6) Mean 51.7 40.4 39.7 13.8 −3.7 −4.5
±SD 32.7 21.9 21.9 6.9 9.3 14.1
p-value ns 0.07 0.01 0.03

Large tumor defined as ≥14 cc at baseline based on the studied populations median.